Fresenius Medical Care AG & Co. KGaAFMSNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +1.95% | +3.32% | +0.54% | +2.62% | -0.29% |
| Gross Profit Growth | -5.85% | +0.88% | +4.15% | +8.40% | +9.31% |
| EBITDA Growth | -68.09% | -4.31% | -0.92% | +2.98% | +206.38% |
| Operating Income Growth | -39.34% | +34.70% | +0.07% | +2.92% | +128.99% |
| Net Income Growth | -64.39% | +113.11% | +20.47% | +29.01% | +388.69% |
| EPS Growth | -72.73% | +333.33% | +143.75% | +147.37% | +850.00% |
| EPS Diluted Growth | -72.73% | +333.33% | +143.75% | +147.37% | +850.00% |
| Weighted Average Shares Growth | +33.37% | -50.00% | -50.00% | -50.18% | -51.28% |
| Weighted Average Shares Diluted Growth | +33.38% | -50.00% | -50.00% | -50.18% | -51.28% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +15.66% | +27.90% | +75.16% | -24.69% | +17.17% |
| Free Cash Flow Growth | +26.07% | +0.00% | +119.27% | -32.95% | -4.55% |
| Receivables Growth | -6.29% | -11.31% | -20.45% | -0.11% | -7.83% |
| Inventory Growth | -5.11% | -6.21% | -10.39% | -0.63% | +3.53% |
| Asset Growth | -1.07% | -4.66% | -7.68% | -5.00% | -7.64% |
| Book Value per Share Growth | -19.75% | +106.69% | +90.52% | +90.81% | +101.12% |
| Debt Growth | -8.88% | -10.08% | -6.40% | -6.72% | -1.90% |
| R&D Expense Growth | -23.48% | -9.04% | -17.14% | -5.63% | +212.91% |
| SG&A Expenses Growth | -0.63% | -3.22% | +2.72% | -6.69% | -6.53% |